INTRAVENOUS IMMUNOGLOBULINS: MECHANISMS OF THERAPEUTIC EFFECTS
Intravenous immunoglobulins (IVIG) are currently the most widely used immunobiological drug derived from donor blood. The IVIG preparations contain antibodies, mostly, of IgG class, obtained from plasma pools of 3,000 to 15,000 donors (over 1000 donors per lot, according to international standards a...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
SPb RAACI
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8ed4342c9bdc4d5fa4a83c4ced64c76c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:8ed4342c9bdc4d5fa4a83c4ced64c76c |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:8ed4342c9bdc4d5fa4a83c4ced64c76c2021-11-18T08:03:43ZINTRAVENOUS IMMUNOGLOBULINS: MECHANISMS OF THERAPEUTIC EFFECTS1563-06252313-741X10.15789/1563-0625-2014-4-311-322https://doaj.org/article/8ed4342c9bdc4d5fa4a83c4ced64c76c2014-08-01T00:00:00Zhttps://www.mimmun.ru/mimmun/article/view/697https://doaj.org/toc/1563-0625https://doaj.org/toc/2313-741XIntravenous immunoglobulins (IVIG) are currently the most widely used immunobiological drug derived from donor blood. The IVIG preparations contain antibodies, mostly, of IgG class, obtained from plasma pools of 3,000 to 15,000 donors (over 1000 donors per lot, according to international standards and guidelines), being used for treatment of various diseases over four last decades. Initially, IVIG application wasaimed for immune support only in primary immunodeficiency states. However, recent clinical and experimental data show effectiveness of the IVIG in systemic and autoimmune diseases, immune-associated infertility and miscarriage. As well as in translantology, hematology and other fields of medicine. Their efficiency is associated with immunomodulatory effects. There is a growing number of publications bearing on this subject and elucidating possible mechanisms of therapeutic effects of IVIG, which are based on the latest basic and clinical research findings in this area. At the same time, much issues remain unclear and contradictory, and some data are mutually exclusive, thus prompting further studies and trials of IVIG preparations. The aim of this article is to summarize the known basic mechanisms of therapeutic effects, main results of recent research in this area,and potential clinical applications of IVIG in future.V. A. LazanovichE. V. ProsekovaSPb RAACIarticleintravenous immunoglobulintherapymechanismImmunologic diseases. AllergyRC581-607RUMedicinskaâ Immunologiâ, Vol 16, Iss 4, Pp 311-322 (2014) |
institution |
DOAJ |
collection |
DOAJ |
language |
RU |
topic |
intravenous immunoglobulin therapy mechanism Immunologic diseases. Allergy RC581-607 |
spellingShingle |
intravenous immunoglobulin therapy mechanism Immunologic diseases. Allergy RC581-607 V. A. Lazanovich E. V. Prosekova INTRAVENOUS IMMUNOGLOBULINS: MECHANISMS OF THERAPEUTIC EFFECTS |
description |
Intravenous immunoglobulins (IVIG) are currently the most widely used immunobiological drug derived from donor blood. The IVIG preparations contain antibodies, mostly, of IgG class, obtained from plasma pools of 3,000 to 15,000 donors (over 1000 donors per lot, according to international standards and guidelines), being used for treatment of various diseases over four last decades. Initially, IVIG application wasaimed for immune support only in primary immunodeficiency states. However, recent clinical and experimental data show effectiveness of the IVIG in systemic and autoimmune diseases, immune-associated infertility and miscarriage. As well as in translantology, hematology and other fields of medicine. Their efficiency is associated with immunomodulatory effects. There is a growing number of publications bearing on this subject and elucidating possible mechanisms of therapeutic effects of IVIG, which are based on the latest basic and clinical research findings in this area. At the same time, much issues remain unclear and contradictory, and some data are mutually exclusive, thus prompting further studies and trials of IVIG preparations. The aim of this article is to summarize the known basic mechanisms of therapeutic effects, main results of recent research in this area,and potential clinical applications of IVIG in future. |
format |
article |
author |
V. A. Lazanovich E. V. Prosekova |
author_facet |
V. A. Lazanovich E. V. Prosekova |
author_sort |
V. A. Lazanovich |
title |
INTRAVENOUS IMMUNOGLOBULINS: MECHANISMS OF THERAPEUTIC EFFECTS |
title_short |
INTRAVENOUS IMMUNOGLOBULINS: MECHANISMS OF THERAPEUTIC EFFECTS |
title_full |
INTRAVENOUS IMMUNOGLOBULINS: MECHANISMS OF THERAPEUTIC EFFECTS |
title_fullStr |
INTRAVENOUS IMMUNOGLOBULINS: MECHANISMS OF THERAPEUTIC EFFECTS |
title_full_unstemmed |
INTRAVENOUS IMMUNOGLOBULINS: MECHANISMS OF THERAPEUTIC EFFECTS |
title_sort |
intravenous immunoglobulins: mechanisms of therapeutic effects |
publisher |
SPb RAACI |
publishDate |
2014 |
url |
https://doaj.org/article/8ed4342c9bdc4d5fa4a83c4ced64c76c |
work_keys_str_mv |
AT valazanovich intravenousimmunoglobulinsmechanismsoftherapeuticeffects AT evprosekova intravenousimmunoglobulinsmechanismsoftherapeuticeffects |
_version_ |
1718422434161360896 |